This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nutrisystem Debuts Its Enhanced Nutrisystem D Diet Plan Specifically Designed For People With Type 2 Diabetes

FORT WASHINGTON, Pa., July 12, 2012 /PRNewswire/ -- Nutrisystem (NASDAQ: NTRI), a leading provider of weight management products and services, today announced the debut of its enhanced weight management plan for people with diabetes, Nutrisystem D. Nutrisystem D is a home-delivered, portion-controlled, nutritionally balanced weight loss program that is based on the science of the low glycemic index and meets the nutritional guidelines of the American Diabetes Association.* The program is specifically designed to help people with type 2 diabetes effectively lose weight and better manage their blood glucose levels.  The basis for the enhanced program includes new clinical findings, a new means of customer access to Certified Diabetes Educators, and a previously announced, expanded relationship as a National Strategic Partner with the American Diabetes Association. * American Diabetes Association: Standards of medical care in diabetes – 2012 (Position Statement). Diabetes Care 35 (suppl.1): S11-S63.

The Importance of Addressing Diabetes

  • Today about 26 million people – roughly 10% of the U.S. adult population – have diabetes, according to the American Diabetes Association; on average, there is a new case of diabetes diagnosed in the U.S. every 17 seconds. 
  • Another 79 million adults over the age of 30 have pre-diabetes, meaning they are at high risk for developing the disease. The disease kills more Americans than breast cancer and HIV combined, and is a major driver of preventable healthcare costs. 
  • Several independent studies, including the NIH multicenter study known as Look AHEAD ( Action for  HEAlth in Diabetes), have shown that losing as little as 5%-10% of body weight can slow the progression of type 2 diabetes, help people improve their glucose, blood pressure and more, and take fewer related costly medications. Being overweight also adds to the risk of medical complications and premature death for those with the disease. 

Clinical Studies

Three separate clinical trials have examined the effects of Nutrisystem D among overweight people with type 2 diabetes. The first two studies showed that those using Nutrisystem D, in combination with counseling sessions, achieved significantly greater reductions in body weight and A1C (a 90-day measure of blood glucose control), than participants who were assigned to control interventions.  Aggregating data from both studies, participants who received the Nutrisystem D intervention lost an average of 18 pounds and reduced A1C by an average of 0.7% at 6 months.  Certain improvements in accompanying metabolic risk factors, such as waist circumference, cholesterol, triglycerides, and systolic blood pressure, also were noted.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs